Related Experiment Video
Updated: Jul 19, 2026

08:28
Monitoring the Wall Mechanics During Stent Deployment in a Vessel
Published on: May 8, 2012
Radiostereometric analysis for monitoring percutaneous physiodesis. A preliminary study
H Lauge-Pedersen1, G Hägglund, R Johnsson
1Department of Orthopaedics, Lund University Hospital, S-22185 Lund, Sweden. Henrik.Lauge-Pedersen@ort.lu.se
The Journal of Bone and Joint Surgery. British Volume
|November 1, 2006
Summary
Percutaneous physiodesis effectively arrests bone growth in children, with most achieving physeal arrest within 12 weeks. This method aids in managing leg length discrepancy and predicted extreme height without causing angular deformities.
Area of Science:
- Orthopedic surgery
- Pediatric orthopedics
- Growth plate management
Background:
- Percutaneous physiodesis is used for leg-length discrepancy and extreme height.
- Incomplete physeal arrest can lead to angular deformities.
- The timing of physeal arrest after percutaneous physiodesis is not well understood.
Purpose of the Study:
- To evaluate the time interval from percutaneous physiodesis to physeal arrest.
- To assess the occurrence of angular deformities after the procedure.
- To determine the efficacy of radiostereometric analysis in monitoring growth retardation.
Main Methods:
- Ten children underwent percutaneous physiodesis (6 for leg-length discrepancy, 4 for extreme height).
- Radiostereometric analysis (RSA) was used to track 3D growth dynamics.
- Measurement precision for translation was <0.05 mm and rotation <0.06 degrees.
Main Results:
- Physeal arrest was achieved in 9 out of 10 children within 12 weeks.
- No clinically significant angular deformities were observed.
- RSA provided precise monitoring of growth retardation.
Conclusions:
- Percutaneous physiodesis is a suitable method for treating leg-length discrepancy and extreme height.
- Early detection of incomplete physeal arrest is possible with RSA.
- The procedure can be repeated if necessary, potentially avoiding corrective osteotomy.

